Imprint Wealth LLC Acquires New Shares in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Imprint Wealth LLC acquired a new stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) in the fourth quarter, Holdings Channel.com reports. The firm acquired 9,111 shares of the pharmacy operator’s stock, valued at approximately $238,000.

A number of other hedge funds have also bought and sold shares of the business. Candriam Luxembourg S.C.A. grew its position in shares of Walgreens Boots Alliance by 0.5% during the 1st quarter. Candriam Luxembourg S.C.A. now owns 63,483 shares of the pharmacy operator’s stock valued at $2,842,000 after purchasing an additional 310 shares in the last quarter. Signet Financial Management LLC lifted its holdings in shares of Walgreens Boots Alliance by 1.0% during the 1st quarter. Signet Financial Management LLC now owns 35,461 shares of the pharmacy operator’s stock worth $1,588,000 after acquiring an additional 334 shares during the last quarter. Cooper Financial Group lifted its holdings in shares of Walgreens Boots Alliance by 4.2% during the 3rd quarter. Cooper Financial Group now owns 10,982 shares of the pharmacy operator’s stock worth $244,000 after acquiring an additional 442 shares during the last quarter. New York Life Investment Management LLC lifted its holdings in shares of Walgreens Boots Alliance by 0.4% during the 3rd quarter. New York Life Investment Management LLC now owns 114,506 shares of the pharmacy operator’s stock worth $2,547,000 after acquiring an additional 499 shares during the last quarter. Finally, Laurel Wealth Advisors Inc. lifted its holdings in shares of Walgreens Boots Alliance by 5.1% during the 1st quarter. Laurel Wealth Advisors Inc. now owns 10,563 shares of the pharmacy operator’s stock worth $473,000 after acquiring an additional 509 shares during the last quarter. 58.59% of the stock is currently owned by hedge funds and other institutional investors.

Walgreens Boots Alliance Price Performance

Shares of WBA opened at $17.64 on Wednesday. The stock has a market cap of $15.22 billion, a PE ratio of -2.52, a price-to-earnings-growth ratio of 1.09 and a beta of 0.73. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.32 and a current ratio of 0.66. Walgreens Boots Alliance, Inc. has a fifty-two week low of $17.53 and a fifty-two week high of $36.14. The firm’s 50-day simple moving average is $20.70 and its two-hundred day simple moving average is $22.02.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings data on Thursday, March 28th. The pharmacy operator reported $1.20 earnings per share for the quarter, topping analysts’ consensus estimates of $0.82 by $0.38. The business had revenue of $37.05 billion for the quarter, compared to analysts’ expectations of $35.86 billion. Walgreens Boots Alliance had a negative net margin of 4.18% and a positive return on equity of 12.11%. The business’s revenue was up 6.3% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.16 earnings per share. Analysts anticipate that Walgreens Boots Alliance, Inc. will post 3.23 earnings per share for the current fiscal year.

Insider Activity

In other news, Director Valerie B. Jarrett purchased 4,456 shares of the business’s stock in a transaction dated Monday, January 29th. The shares were purchased at an average price of $22.44 per share, for a total transaction of $99,992.64. Following the completion of the acquisition, the director now directly owns 4,456 shares in the company, valued at approximately $99,992.64. The purchase was disclosed in a document filed with the SEC, which is accessible through the SEC website. In related news, Director Valerie B. Jarrett acquired 4,456 shares of the stock in a transaction that occurred on Monday, January 29th. The shares were bought at an average price of $22.44 per share, for a total transaction of $99,992.64. Following the completion of the transaction, the director now directly owns 4,456 shares in the company, valued at $99,992.64. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Inderpal S. Bhandari acquired 3,000 shares of the stock in a transaction that occurred on Thursday, April 11th. The shares were bought at an average price of $18.05 per share, for a total transaction of $54,150.00. Following the transaction, the director now owns 3,000 shares of the company’s stock, valued at $54,150. The disclosure for this purchase can be found here. Insiders have bought a total of 13,456 shares of company stock worth $270,423 over the last 90 days. 17.40% of the stock is currently owned by insiders.

Analyst Ratings Changes

WBA has been the subject of a number of research analyst reports. Barclays assumed coverage on shares of Walgreens Boots Alliance in a report on Wednesday, January 3rd. They set an “underweight” rating and a $21.00 price objective for the company. Bank of America lowered their price target on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set an “underperform” rating for the company in a research note on Tuesday, March 26th. TD Cowen lowered their price target on shares of Walgreens Boots Alliance from $37.00 to $35.00 and set a “buy” rating for the company in a research note on Wednesday, April 3rd. Raymond James reaffirmed a “market perform” rating on shares of Walgreens Boots Alliance in a research note on Tuesday, March 26th. Finally, Morgan Stanley lowered their price objective on shares of Walgreens Boots Alliance from $21.00 to $20.00 and set an “underweight” rating for the company in a research note on Monday, April 1st. Four investment analysts have rated the stock with a sell rating, ten have given a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $24.36.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.